Short answer
DaVita (DVA) filed its Q2 2025 10-Q quarterly report on Aug 5, 2025 for the quarter ended Jun 30, 2025. Quarterly revenue was $3.4B (up 6.1% year over year) with net income of $199M.
Q2 2025 key financials · XBRL
- Revenue
- $3.4B
- +6.1% YoY · +4.8% QoQ
- Net income
- $199M
- −10.5% YoY · +22.4% QoQ
- Operating margin
- 15.9%
- EPS (diluted)
- $2.57
- +2.8% YoY · +28.5% QoQ
Source: XBRL data from the DaVita (DVA) Q2 2025 10-Q on SEC EDGAR. USD.
DaVita Q2 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New cybersecurity risk: $13M charges in Q2 2025 from incident remediation, excluded from non-GAAP results reflecting non-recurring nature
- Updated tax risk: Effective income tax rate rose to 31.9% in Q2 2025 from 22.9% in H1 2024, driven by changes in tax expense allocation
- Legal risk: Put provisions create obligations to purchase noncontrolling interests in majority-owned dialysis partnerships exercisable at third-party discretion
- Operational risk: Purchase agreements require minimum dialysis equipment and supply commitments under penalty for shortfall, impacting vendor relationships
- Financial risk: Letters of credit totaled approx. $159M as of June 30, 2025 under secured facility separate from senior secured credit facilities
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other DaVita quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.